2024 Update in Hematology and Medical Oncology


2024 Update in Hematology and Medical Oncology Banner

Add to Calendar 2024 Update in Hematology and Medical Oncology 3/8/2024 9:00:00 AM 3/11/2024 12:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=42833 Description: The Memorial Sloan Kettering 12th Annual Hematology and Medical Oncology Board Review is a four day course that provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck,... Online false MM/DD/YYYY


Date & Location
Friday, March 8, 2024, 9:00 AM - Monday, March 11, 2024, 12:00 PM, Online

Specialties
Specialties - Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

The Memorial Sloan Kettering 12th Annual Hematology and Medical Oncology Board Review is a four day course that provides an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty will focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, central nervous system oncology, and hematologic oncology. Ample time will be provided at the conclusion of each presentation for an interactive question-and-answer session with the speakers.

Attendees of this course will receive access to an online syllabus, which includes select PDFs of presentations (slides) and video recordings of the lectures.

Target Audience

The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. This course is designed to enable participants to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

This course is set to be an exclusively live virtual experience. Detailed Zoom access and participation instructions will be provided to registrants prior to the start of the program.

Objectives
  1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
  2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
  3. Prepare for ABIM examinations in medical oncology and hematology.

Registration

Virtual Registration Fees

  • Physicians (MDs, PhDs, and DOs): $1,650
  • APPs, Residents, Fellows, Nurses, and Other Healthcare Providers: $1,075
  • Industry Professionals*: $2,885

A registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend a CME course at MSK. If you are a member of one of these groups, please submit your request here for a promotion code to be applied at registration. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

*Industry professionals may attend CME activities at MSK for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 31.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 31.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.